proved by the FDA for use in coronary bypass surgery and other vascular bypass grafting procedures. This system was evaluated in a study in cadavers as well as in a rabbit abdominal aorta bypass model with a craniotomy simulator.
Materials and Methods

Automated Anastomosis Device and Surgical Use
For performing the automated anastomosis, the C-Port xA was used in both the anatomical cadaver study and the in vivo rabbit aorta bypass model. The C-Port xA integrates in 1 tool the functions necessary to enable rapid, automated end-to-side anastomoses. This product is designed for a single anastomosis. When using the Cardica CPort xA system, a vein or arterial graft is attached to the cartridge of the C-Port xA deployment device ( Figs. 1 and 2 ). The graft must have a double wall thickness of Յ 1.4 mm. There is no minimum diameter on the outer diameter of the graft. The surgeon creates a small incision in the graft, typically 7-10 mm in length, and inserts the graft between the 2 cartridge arms. The graft is attached to 1 small spike at the heel of the anastomosis and is temporarily secured to the cartridge with 2 conduit clamps. A shield is tucked into the lumen of the graft. The C-Port can be deployed into target vessels with a minimum internal diameter of 1.3 mm and a wall thickness of 0.75 mm. The target vessel should be suitable for a hand-sewn anastomosis, that is, be free of severe disease. For deployment, the tool is prepared by activating a CO 2 cartridge that serves as the energy source. The CO 2 allows a gentle deployment without recoil that otherwise could disturb the target vessel or the anastomosis. The surgeon then dissects the target vessel as is typically done for a handsewn anastomosis. A length of 18 mm of dissected surface is required to allow deployment of the C-Port. A U or Z stitch with 9-0 Prolene is placed at the proximal end of the intended anastomosis site. A small incision is made inside the stitch to allow insertion of the C-Port xA anvil ( Fig. 3A and B) . The anastomosis can therefore be performed with or without temporary occlusion depending on the operative site. If temporary occlusion is required, it can easily be performed in Ͻ 60 seconds. For creation of the anastomosis the surgeon depresses the trigger. This results in the cartridge closing on the target vessel, followed by deployment of 13 staples that circumferentially connect the graft to the target vessel in a compliant fashion ( Fig. 3C and D) . At the same time an arteriotomy knife located inside the anvil automatically creates an arteriotomy of ~ 4.65 mm in length ( Fig. 3E and F) . On completion of the anastomosis, the surgeon releases the trigger, allowing the cartridge to unclamp, and then the anvil is removed from the target vessel (Fig. 3G) . The previously placed anvil insertion hole stitch is tied, which completes the entire procedure (Fig. 3H) .
Cadaver Studies
Four Thiel-fixated cadaveric heads were used to determine the applicability and feasibility of using the C-Port xA to create an anastomosis to the end segment of the ICA and the MCA by using a standard pterional craniotomy (8 exposures). Standard microsurgical techniques to access the basal cisterns, intracranial segment of the ICA, and MCA were used. The distance from the craniotomy level to the carotid end segment and MCA bifurcation as well as the lengths of the respective arterial segments were measured. The length and dimensions of the different segments were defined as follows: the M 1 segment extending from the carotid bifurcation to the first even MCA bifurcation and the M 2 segment from this last point to the next bifurcation. Subjective ease, applicability, and possible improvements regarding the deployment and insertion of the anvil into the target host vessel were assessed.
Craniotomy Simulator
The craniotomy model was made of Persplex and consisted of a plate with an 8-cm hole simulating the pterional craniotomy. The height of the craniotomy model was adjusted to the size of the rabbit to maintain a distance of 10 cm between the craniotomy and the abdominal aorta (Fig. 4) .
In Vivo Rabbit Abdominal Aorta Craniotomy Simulation Studies
Ten New Zealand rabbits weighing Ͼ 3.5 kg underwent induction of anesthesia and surgery according to the protocol approved by the local committee for conduct of animal research. Following intubation and pressure-controlled ventilation, the animals received 100 ml of saline containing 500 IU heparin intravenously. The animals were placed on a temperature-controlled heating pad. The procedures were performed using aseptic techniques. The intestines were exposed through a midline abdominal incision and protected with gauze soaked in warm water and then encased in aluminum foil to prevent hypothermia. Dissection of the abdominal aorta was blunt. The remainder of the procedure was performed using the craniotomy simulator. For the abdominal aortic bypass, 2 C-Port xA devices were attached to an ePTFE graft (International Polymer Engineering) 10 Ϯ 1.5 cm in length depending on the individual anatomy of the abdominal artery. To avoid any blood loss, the anastomoses were performed following temporary occlusion of the aorta. A small incision was made for each anastomosis to facilitate introduction of the C-Port xA anvil. Following completion of the anastomoses, the temporary occlusion was released. A permanent clip was placed on the abdominal aorta between the 2 anastomoses and superior to any larger spinal artery within that segment. The intestines were replaced carefully with focus on minimizing compression of the bypass graft. The abdomen was closed using standard technique. Subcutaneous Fraxiparine 850 IU anti-factor Xa (GlaxoSmithKline AG) was administered according to body weight. On the 2nd postoperative day, abdominal angiography was performed after induction of general anesthesia in 8 of the 10 animals as a final procedure by injecting 5 ml Iopamiro through a proximally advanced catheter placed in the subclavian artery. The remaining 2 animals were killed after 1 month for histological evaluation of the anastomoses. As the long-term patency of the C-Port system had been previously studied in humans, 7 the main focus of this study was not long-term patency but technical feasibility. However, this study is the first to evaluate the use of ePTFE as the conduit in conjunction with the C-Port xA. The bypass was excised and fixin formalin and subsequently embedded in methyl methacrylate resin over a 10-day period for slow hardening. Tissue slices 150 m thick were obtained using a diamond band saw (Exact Apparatebau). Thereafter, the slices were polished to a thickness of 50 m. After pretreatment with paragon solution, the slices were stained with cresyl violet.
Results
Anatomical Studies
Feasibility in the Cadaver Studies. A total of 8 craniotomies were performed, and we focused on the ICA, the syl-
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Automated end-to-side anastomosis to the MCA 569 FIG. 2. Schematic depicting the loading technique of the C-Port xA. In panels A and C, 1 denotes the anvil; 2, the heel clip; 3, the cartridges; 4, the piercer; 5, the shield; and 6, the clamp. Note the distal end of the graft (A) that will be located at the heel of the anastomosis. An incision ~ 6-8 mm long is created extending up this side, long enough to allow the distal end of the graft to cover the entire cartridge surface area. The shield (5) is flipped outward so that the tip of the shield is facing away from the cartridge. The piercer (4) is rotated upward until it stops. This action will expose the tip of the heel clip. In panels B and C, forceps are used to advance the graft, incised edge first, between the cartridge arms (3). This action can be facilitated by using a second forceps to grasp the graft on the underside of the cartridge while sliding in between the arms. With the aid of the forceps the 2 flaps of the graft are grasped at the base of the incision and held above the tine of the heel clip (2) . In panels D and E, the conduit is held in position as the left graft clamp is lowered with the piercer (4) until it has fully pierced the conduit on the heel clip (2) . Once the graft is aligned and the graft tissue completely covers the full length of both loading platforms, the left graft clamps are lifted to the upper-most position and the piercer is slid forward to detach. The 2 graft clamps are then lowered (6) . The C-Port xA is ready for the target vessel anastomosis.
vian fissure, and its vessels. In all 8 MCA exposures, there was sufficient space and length of an M 1 /M 2 segment available to perform a C-Port xA anastomosis. The anastomosis was placed in 8 of 8 cases in the M 1 segment. Brain fixation required more brain retraction force than usual in the clinical situation. The anatomical views of the C-Port xA in the sylvian fissure and a preformed ePTFE graft bypass are shown in Fig. 5 . Figure 6 shows the excised graft together with the MCA and the anastomosis site from the endoluminal side. As a general rule the wider the sylvian fissure is opened, the more proximal the C-Port xA can be applied. The opening of the cartridge arm and the size of the anvil necessitate a distance of 18 mm, which is considered not to be a limitation if the anastomosis lies superficially parallel to the sylvian fissure, but may be an obstacle as the size of the cartridge arm may hide the anvil insertion procedure in more proximal anastomosis or a tight brain environment.
Anatomical Findings of the Cranial Vessels. In the 8 cadavers we measured the following vessel lengths (mean Ϯ standard deviation): ICA 8.5 Ϯ 1.5 mm, M 1 18.7 Ϯ 6.5 mm, and M 2 13.1 Ϯ 5.1 mm.
In Vivo Animal Studies
Feasibility of the Craniotomy Simulator. A total of 20 CPort xA anastomoses were performed using the craniotomy simulator. The craniotomy simulator reproduced the size and the depth of a standard pterional craniotomy. Visibility and access were sufficient for a single C-Port xA anastomosis (Fig. 4) . In this particular study, both ends of the bypass graft were preattached to a C-Port xA, which, when inserted simultaneously through the craniotomy simulator, did affect visibility and access.
Angiograms. Intraarterial angiography on the 2nd day was performed in the 8 animals available for early evaluation, and the grafts were patent in all cases with no signs of stenosis at the site of the anastomoses. The angiographic findings of the 2 animals killed at 1 month showed no evidence of stenosis with contrast media flow through the bypass (Fig. 7) .
Histological Findings. The 1-month histological studies performed in 2 animals demonstrated minimal intimal hyperplasia at the site of the anastomosis. The ePTFE vessel grafts showed good endothelialization, which was in accordance with the good clinical outcome (Fig. 8) .
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Discussion
Cerebrovascular diseases such as giant aneurysms and carotid/intracranial occlusions will in the future be primarily treated using endovascular techniques. The remaining cases consist of those that are difficult to treat with either a microsurgical or a combined microsurgical-endovascular approach. These approaches are often associated with high morbidity and mortality rates. The latter may only be positively affected by concentration of expertise in specialized centers and by the development of novel procedures. New techniques such as the Excimer Laser-Assisted Non-Occlusive Anastomosis technique have been reported as methods suitable for treating vessels 3 mm and larger. This technique is currently under investigation for FDA approval.
The C-Port xA is both FDA-and Consultants Europeapproved for creation of anastomoses in blood vessels and grafts, including use in coronary artery bypass grafting procedures. Its long-term patency was demonstrated through controlled clinical trials in patients undergoing coronary bypass procedures. The primary aim of our study was to test the feasibility of this facilitated automated anastomosis in intracranial vessels.
Cadaver Studies
Based on our findings in this study with respect to the current specifications of the C-Port xA, the MCA is currently the most suitable target vessel. However, there is great variability of the length and branching pattern of intracranial arteries, especially for the MCA. Gibo et al. 1 and Tanriover and colleagues 11 reported that the main trunk of the MCA divides in 1 of 3 ways: bifurcation into superior and inferior trunks (78%); trifurcation into superior, middle, and inferior trunks (12%); or division into multiple (4) trunks (10%). Furthermore, the comparison between different studies is complicated by a nonuniform definition of the different segments of the MCA, focusing either more on the anatomical local conditions of the sylvian fissure or on the strict bifurcation pattern. Tanriover et al. recorded the length of the MCA segment starting from the end segment of the ICA to the first MCA and termed it the prebifurcation part of the M 1 segment. These authors measured an average length of 17.8 mm (range 10-29 mm). [3] [4] [5] [6] We defined our segments based strictly on the bifurcation pattern primarily to determine the feasibility of C-Port xA use and also with regard to future clinical use and preoperative angiographic assessment. The length of the MCA segments as determined in the present study are comparable to those previously reported and, therefore, the conclusion we draw in regarding feasibility and suitability of the C-Port xA for MCA access should be representative of a typical clinical presentation.
The dimensions of the C-Port xA necessitate a vessel distance of 10 mm, corresponding to the micromechanical requirements of the length of the anvil. In our anatomical study, it was possible in each case to access the artery and place a C-Port xA anastomosis. For an optimum placement of the C-Port xA anastomosis, the anatomical limits of M 1 and M 2 can be disregarded because the anvil can be inserted into the M 2 segment, resulting in anastomosis placement in the M 1 segment. The visual control of the anvil insertion site may be temporarily lost during deployment, but is immediately regained thereafter. The fact that the deployment is achieved using a pressurized CO 2 system minimizes tool movement and allows the user to accurately align the anvil with the insertion hole and the target vessel. Although the actual distance for insertion and thus the anastomosis is 10 mm, the current specifications of the deployment system necessitate the target vessel being dissected over a length of 18 mm. The target vessel can follow a tortuous path. Such a distance is achievable only by opening the sylvian fissure, in consideration of the minimal target vessel size of 1.3 mm.
In Vivo Craniotomy Simulation Studies
The in vivo studies performed on the rabbit abdominal aorta model as a craniotomy simulator model are consid- ered representative of a conventional pterional craniotomy used for the high-flow bypass to the MCA. Our experiments were further challenging because of the need to simultaneously introduce 2 C-Port xA systems through the simulated craniotomy to perform a jump graft on the abdominal aorta of the rabbit. The size of this vessel corresponds well to the human MCA in terms of outer diameter and thickness. We used ePTFE vessel grafts because the rabbit does not offer any autologous large conduits suitable for this bypass model. The long-term patency rates achieved using the C-Port xA for coronary artery bypass have been previously demonstrated. 7 The 1-month C-Port xA anastomosis site showed only minimal intimal hyperplasia, a phenomenon we previously demonstrated in a study by using an ePTFE vessel graft in a similar endto-side anastomosis on the abdominal aorta of the rabbit for a follow-up period of 180 days. 9 These in vivo studies did show good feasibility for vascular anastomosis created with the C-Port xA as evidenced by excellent short patency and low complication rates. Further clinical studies with this product will be beneficial in providing data on longterm patency in cerebral bypass.
Current Application Specifications for C-Port xA
The C-Port xA is currently used for vascular bypass in coronary and arterial bypass surgery, although it has been approved by the FDA for the creation of anastomoses in any blood vessel and grafts. In coronary surgery the grafts used have been the saphenous vein and radial and internal mammary arteries. Clinically, there has been no experience with artificial grafts, such as the ePTFE grafts used in this study. Graft limitations are that the double wall thickness should not exceed 1.4 mm. In beating-heart coronary bypass procedures the C-Port xA is generally used without occluding the native target vessel, thereby avoiding or minimizing myocardial ischemia. Based on our limited experience derived from this study in the intracranial application of this technology, we see an advantage of having a temporary occlusion of the target to improve visibility and access. The graft can be connected on the proximal end before deployment of the distal anastomosis. Based on the dimensional requirements stated earlier, a bypass between the superficial temporal artery and the MCA is technically possible. The current dimensions of the C-Port xA limit the anastomosis to the end segment of the carotid artery, M 1 , M 2 , and possible large M 3 branches. Cortical arteries smaller than 1.3 mm are not suitable for the current C-Port xA device, and thus anastomosis to cortical arteries is not possible.
Technical Improvements and Clinical Impact for Intracranial Use
During the insertion phase of the anvil and the final positioning of the C-Port xA, the view of the prospected anastomosis site may be impaired. This may be improved by rounding and reducing the shape and size of the cartridge arms. The manufacturer has recently launched a new iteration of the C-Port line, the C-Port Flex A, in which the cartridge can be uncoupled from the deployment handle, thereby significantly improving access and visibility. For a bypass procedure in the posterior fossa in addition to the uncoupling of the handle and the cartridge arms, a further miniaturization would be necessary, and, especially, the opening angle between anvil and cartridge arms would need to be reduced. The results of this study are encouraging in that a clinical application of this particular device for the end-to-side bypass on the MCA in vivo seems technically feasible.
Conclusions
The anatomical studies as well as the in vivo craniotomy simulated rabbit jump graft bypass studies have demonstrated that the dimensions of the facilitated automated endto-side anastomosis device are suitable for an extracranial to intracranial high-flow bypass on the MCA. This technique may enable an anastomosis with much shorter branch occlusion times compared with conventional anastomosis techniques. Further miniaturization and special adaptation of this device would be beneficial to improve access to more proximal intracranial targets.
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